GRANDMASTER: Gauging the Role of Alertness and Neurostimulation With Dietary Caffeine in Master-Level Chess; A Double-Blind Randomized Crossover Trial
| Registry | NCT07641335, acronym GRANDMASTER |
|---|---|
| Status | Recruiting |
| Phase | Not applicable |
| Study type | Interventional; randomized, crossover, masking: triple, basic science |
| Enrollment | 12 (Estimated) |
| Sponsor | St. Louis University (Other) |
| Conditions | Cognitive Performance, Attention, Reaction Time, Caffeine |
| Interventions | Caffeinated Coffee, Decaffeinated Coffee Placebo (Dietary supplement) |
| Dates | start 2026-08-25, primary completion 2027-07-30 (estimated), completion 2027-08-30 (estimated), first posted 2026-06-11, last updated 2026-09-30 |
| Locations | 1 site in United States |
Related Papers Related Patents Related Grants Related Experts
All trials for Cognitive Performance All trials for Attention All trials of Caffeinated Coffee All trials of Decaffeinated Coffee Placebo
This study will examine whether caffeine improves cognitive and competitive performance in professional chess players during tournament-style games. In a randomized double-blind crossover design, participants will complete two experimental sessions in which they consume either caffeinated coffee or decaffeinated coffee before playing a standardized chess match. Cognitive performance will be assessed using attention and reaction-time tests, including the Stroop Test, Trail Making Test, and Puzzle Rush task. Chess performance outcomes such as move accuracy, time management, and error rates will also be evaluated. The study aims to determine whether moderate caffeine intake enhances focus, alertness, and decision-making during prolonged competitive chess play.
This randomized double-blind crossover trial will evaluate the effects of moderate caffeine intake on cognitive and competitive performance in professional chess players. Twelve FIDE-rated chess players will complete two experimental conditions in randomized order: caffeinated coffee and decaffeinated coffee placebo. During each visit, participants will complete standardized cognitive assessments and a tournament-style chess game under controlled laboratory conditions.
Primary outcomes will include objective chess performance metrics derived from chess engine analysis, including move accuracy, centipawn loss, error rates, and time management. Secondary outcomes will include cognitive test performance, tactical reaction time, and self-reported alertness and fatigue. Chess games will be analyzed using standardized software-based evaluation methods.
The crossover design allows each participant to serve as their own control, minimizing variability related to individual differences in skill level, caffeine tolerance, and playing style. The study aims to determine whether caffeine enhances sustained attention, decision-making, and competitive chess performance during prolonged gameplay. Findings may provide insight into nutritional strategies for cognitive performance optimization in mentally demanding competitive environments.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Caffeinated Coffee | Active comparator | Dietary Supplement: Caffeinated Coffee | Participants will consume one serving of black caffeinated coffee prepared from 15 g of ground coffee brewed in 200 g of water, providing approximately 100 mg of caffeine. The beverage will be consumed approximately 30 minutes before completion of cognitive testing and a standardized tournament-style chess game during the experimental visit. |
| Decaffeinated Coffee Placebo | Placebo comparator | Dietary Supplement: Decaffeinated Coffee Placebo | Participants will consume one serving of black decaffeinated coffee prepared to match the caffeinated coffee in taste and appearance. The beverage will be consumed approximately 30 minutes before completion of cognitive testing and a standardized tournament-style chess game during the experimental visit. |
Sex: All, ages: 18 Years to 50 Years, accepts healthy volunteers
Inclusion Criteria: * Male and female professional chess players aged 18-50 years * Current Fédération Internationale des Échecs (FIDE) standard rating between 2300 and 2600 Elo, or achievement of a standard FIDE rating within this range during the previous 12 months * Habitual caffeine consumers consuming ≤2 cups of coffee per day * Willingness to comply with all study procedures and study visits * Ability to provide written informed consent Exclusion Criteria: * Non-caffeine users * Habitual caffeine intake exceeding 2 cups of coffee per day * Cardiovascular disorders * Metabolic disorders * Psychiatric disorders * Pregnancy or breastfeeding * Current smoking * Shift workers * Use of psychoactive medications * Participation in another clinical trial within the previous 3 months * Known allergy or intolerance to milk proteins, dairy products, or soy * Known red-green color blindness or other color vision deficiencies that may interfere with Stroop Test performance
| Facility | City | Country | Status |
|---|---|---|---|
| Saint Louis University | St Louis, Missouri | United States | Recruiting |